Crestovo Investor LLC 13D and 13G filings for Finch Therapeutics Group, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-04-01 5:22 pm Purchase | 2021-03-23 | 13D | Finch Therapeutics Group, Inc. FNCH | Crestovo Investor LLC | 421,381 26.800% | 421,381 (New Position) | Filing |